GLP-1 'weight loss shot' TikToks: what the science actually says

What did @dadollsamira2 actually say?

The creator documented her self-administered injection of what she calls "Zepit type" mixed with vitamin D, claimed she lost 12 pounds, and offered personal safety advice about eating before injections. She said she experienced nausea and vomiting after injecting on an empty stomach following a break from the medication. She disclosed she was off the shot during a trip to Jamaica and returned to it. She tagged a provider she calls "Dr. Rhoda" and avoided showing the vial on camera, citing TikTok's content policies.

A few things worth flagging immediately: she never clarified whether this is brand-name tirzepatide (Zepbound or Mounjaro) or a compounded version. That distinction matters legally, clinically, and from a safety standpoint, and she glossed right over it.

Does the science back this up?

The core premise, that tirzepatide produces meaningful weight loss, is well-supported. The bigger questions are around her specific framing of side effects and her vitamin D mixing claim.

Tirzepatide's efficacy is not in dispute. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed participants on 15 mg tirzepatide lost an average of 20.9% of body weight over 72 weeks. Losing 12 pounds is plausible, especially early in treatment.

The nausea and vomiting she described after eating McDonald's on an empty stomach mid-cycle is consistent with how GLP-1/GIP dual agonists work. These drugs slow gastric emptying significantly. Eating high-fat, calorie-dense food while gastric motility is suppressed is a well-documented trigger for GI distress (Nauck et al., 2021, Nature Reviews Drug Discovery). She is not wrong here. She is describing pharmacology correctly, even if she doesn't know the mechanism.

The vitamin D mixing claim is where things get murky. There is no peer-reviewed evidence supporting mixing tirzepatide with vitamin D in a single injection. This is not a standard pharmaceutical practice for either compound.

What did they get wrong (or right)?

Credit where it's due: her core advice, "eat the way you need to eat" before injecting, is clinically sound. GI side effects on GLP-1-class drugs are strongly correlated with dietary choices, and starting back after a medication break with a high-fat meal is genuinely asking for trouble. She learned this the hard way and reported it honestly.

What she got wrong, or at least dangerously incomplete, is the vitamin D mixing. She presented it casually as if it's a routine thing. It is not. Combining compounds in a single syringe without pharmaceutical guidance raises sterility, stability, and dosing accuracy concerns. No compounding pharmacy protocol I'm aware of recommends this as a standard patient practice. If her provider instructed this, that provider should be explaining the rationale on camera, not leaving it to a 36K-view TikTok to normalize.

She also said she had "no side effects," then immediately described vomiting. That is a side effect. It's a minor framing problem but it could mislead viewers into thinking they should have a completely smooth experience and that vomiting means something is wrong uniquely with them.

What should you actually know?

If you are considering a tirzepatide-based weight loss program, a few things the video does not tell you are worth knowing.

• Compounded tirzepatide and brand-name Zepbound or Mounjaro are not interchangeable. The FDA has raised concerns about compounded versions, including inconsistent dosing and lack of the same safety data (FDA Drug Shortages guidance, 2023-2024).
• GI side effects, including nausea, vomiting, and diarrhea, affect a significant portion of users. In SURMOUNT-1, nausea occurred in up to 31% of participants on the highest dose. These are not rare edge cases.
• Stopping and restarting GLP-1 class medications, as she did for her trip, typically requires dose re-titration to reduce side effects. Her provider should be guiding that process, not the patient improvising.
• Mixing any injectable compound at home without explicit pharmacy or prescriber guidance is a sterility and dosing risk. Do not normalize this based on a social media video.
• Weight loss on these medications tends to plateau and can reverse after stopping. The 12-pound figure is a snapshot, not a guaranteed trajectory.